期刊文献+

慢性稳定型心绞痛的治疗 被引量:10

Treatment of chronic stable angina
下载PDF
导出
摘要 慢性稳定型心绞痛是冠状动脉粥样硬化性心脏病(冠心病)心肌缺血引起的胸前区不适感,邻近区域也可能波及。通常因冠状动脉粥样硬化狭窄,在心脏氧耗增加时无法充分供氧所致。该文重点讲述慢性稳定型心绞痛的药物治疗以及药物治疗的选择策略,并简述非药物治疗方法如血管重建、增强型体外反搏(EECP)以及危险因素的预防。该病的治疗目标是降低死亡率及其他心血管事件发生率,改善生活质量以及减少疼痛。所有患者都应服用他汀类降胆固醇药物和阿司匹林抗血小板。氯吡格雷可作为阿司匹林用药禁忌患者的替代治疗。对置入支架的患者,术后除同时接受阿司匹林和氯吡格雷二联抗血小板治疗,还应接受β受体阻断药及ACEI改善预后,尤其对于合并高血压、左心室收缩功能不全及心力衰竭的患者。在此基础上,如患者仍有心绞痛发作,需考虑行血管重建术,包括PCI治疗和冠状动脉旁路移植术。EECP也是一种有效的治疗方法。 Chronic stable angina pectoris is a discomfort located in the chest, which is caused by myocardial ischemia, adjacent areas possibly involved. It is most commonly caused by the inability of narrowed atherosclerotic coronary arteries to supply adequate oxygen to the heart under conditions of increase demand. This review article focused on the medical treatment of chronic stable angina, with a focus on new strategies or medications. The goals of treatment are mainly to decrease mortality and other cardiovascular events as well as to improve quality of life and relief chest pain. All patients should be on aspirin unless they are allergic or with other contraindications. If so, clopidogrel should be an alternative to aspirin. In addition, clopidogrel is ap-plied to patients who are intolerant to aspirin and those who need combined antiplatelet therapy after stent im-plantation. Patients should be started on beta blockers and angioteusin converting enzyme inhibitors (ACEI), especially for those complicated with hypertension, left ventricular systolic dysfunction and heart failure. For those patients with refractory angina, revascularization should be considered, including percutaneous coronary intervention (PC/) and coronary artery bypass grafting (CABG). Also, the enhanced external counterpulsation (EECP) is a kind of effective measure for chronic stable angina.
作者 吴芳 马虹
出处 《新医学》 2013年第6期359-362,共4页 Journal of New Medicine
关键词 稳定型心绞痛 他汀类降胆固醇药物 阿司匹林 Β受体阻断药 血管紧张素转换酶抑制剂 体外反搏 Stable angina Statins Aspirin β blockers Angiotensin converting enzyme inhibi-tor Counterpulsation
  • 相关文献

参考文献19

  • 1Fraker TD Jr, Fihn SD, Gibbons R J, et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angi- na : a report of the American College of Cardiology/Amer- ican Heart Association task force on practice guidelines writing group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation, 2007, 116: 2762-2772.
  • 2Skalidis El, Vardas PE, et al. Guidelines on the man- agement of stable angina pectoris. Eur Heart J, 2006, 27 : 2606-2607.
  • 3Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summaz'y: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J, 2006, 27: 1341-1381.
  • 4无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2053
  • 5Angina Treatment Pattern Survey Collaborative Group. Current status of medical therapy of chronic stable angi- na pectoris in mainland of China: the second survey. Zhonghua Xin Xue Guan Bing Za Zhi, 2010, 38: 1060-1064.
  • 6Fassa AA, Urban P. Stents and antiplatelet therapy. Adv Cardiol, 2012, 47: 114-124.
  • 7Isshiki T, Kimura T, Ueno T. Clopidogrel trial in pa- tients with elective pereutaneous eoronary intervention for stable angina and old myocardial infarction (CLEAN) . Int Heart J, 2012, 53. 91-101.
  • 8Liang M, Liew TV, Purl A, et al. Medium to long-term clinical outcomes with everolimus-eluting stents in real- life percutaneous coronary intervention. Ann Acad Med Singapore, 2012, 41: 252-257.
  • 9European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/ EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias ofthe European Society of Cardiology (ESC) and the Eu- ropean Atherosclerosis Society (EAS) . Eur Heart J, 2011, 32: 1769-1818.
  • 10Javed U, Deedwania PC, Bhatt DL, et al. Use of inten- sive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: an analysis of 65, 396 hospi- talizations from 344 hospita participating in Get With The Guidelines (GWTG). Am Heart J, 2011, 161: 418-424.

二级参考文献81

  • 1汪志刚,张苗青,郑振声,刘东红,张坡,王西富.体外反搏对冠心病患者血管内皮及其功能的影响[J].中国循环杂志,2006,21(6):416-418. 被引量:6
  • 2Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 3Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 4Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 5Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 6O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 7Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 8Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
  • 9Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
  • 10Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.

共引文献2087

同被引文献80

引证文献10

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部